Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Femoral catheter removal after coronary angiography is a common clinical procedure that may cause pain, anxiety, and changes in vital signs in patients. Non-pharmacological interventions are increasingly used to improve patient comfort and safety during invasive procedures.
The purpose of this randomized controlled study is to evaluate the effect of a virtual reality (VR) application on pain, anxiety, and vital signs during femoral catheter removal in patients undergoing coronary angiography. Participants were randomly assigned to either a virtual reality group or a control group receiving routine care. Patients in the intervention group experienced a virtual reality application during femoral catheter removal, while the control group received standard clinical care.
Pain intensity, anxiety levels, and vital signs were assessed before, during, and after the procedure. The findings of this study are expected to contribute to evidence-based nursing practice by supporting the use of virtual reality as a safe and effective non-pharmacological method to reduce discomfort during femoral catheter removal.
Coronary angiography is a widely used diagnostic procedure in cardiology, and femoral arterial access remains common in many clinical settings. Removal of the femoral catheter following the procedure is frequently associated with pain, anxiety, and physiological responses such as changes in blood pressure and heart rate. These symptoms may negatively affect patient comfort and overall procedural experience.
Virtual reality (VR) is a non-pharmacological intervention that provides immersive audiovisual stimulation and has been shown to reduce pain and anxiety by diverting attention and promoting relaxation. However, evidence regarding its effectiveness during femoral catheter removal after coronary angiography remains limited.
This single-center, randomized controlled trial was conducted to determine the effect of virtual reality on pain intensity, anxiety levels, and vital signs during femoral catheter removal in patients undergoing coronary angiography. Eligible patients were randomly assigned to either the virtual reality intervention group or the control group. Patients in the intervention group received a virtual reality application during femoral catheter removal, while patients in the control group received routine clinical care.
Data were collected using a patient information form, a visual analog scale for pain assessment, a standardized anxiety assessment tool, and vital signs monitoring. Measurements were obtained before, during, and after femoral catheter removal. The results of this study aim to provide evidence supporting the integration of virtual reality into nursing care practices to enhance patient comfort and improve the quality of care during invasive cardiovascular procedures.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Virtual Reality Group | Experimental | Participants received a virtual reality application during femoral catheter removal in addition to routine clinical care. |
|
| Control Group | No Intervention | Participants received routine clinical care during femoral catheter removal without any additional intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Reality | Other | A virtual reality application providing immersive audiovisual content was used during femoral catheter removal to reduce pain and anxiety. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain intensity measured by Visual Analog Scale (VAS) | Pain intensity will be assessed using the Visual Analog Scale (VAS), scored from 0 (no pain) to 10 (worst pain). Higher scores indicate greater pain intensity. | Before femoral sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| Measure | Description | Time Frame |
|---|---|---|
| Anxiety level measured by State Anxiety Inventory (STAI-S) | Anxiety will be measured using the State-Trait Anxiety Inventory - State Form (STAI-S), assessing state (situational) anxiety only. The scale consists of 20 items, with scores ranging from 20 (low anxiety) to 80 (high anxiety). Higher scores indicate greater anxiety. | Before sheath removal (baseline) and immediately after sheath removal |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kayseri City Hospital | Kayseri | Turkey (Türkiye) |
Individual participant data will not be shared due to ethical restrictions and to protect participant confidentiality. The data are used solely for the purposes of this study.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| D001008 | Anxiety Disorders |
| D003324 | Coronary Artery Disease |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001523 | Mental Disorders |
Not provided
Not provided
Participants were randomly assigned to either the virtual reality intervention group or the control group receiving routine care, and both groups were followed in parallel throughout the study.
Not provided
Not provided
Not provided
Not provided
| Heart rate measured in beats per minute (bpm) | Heart rate will be measured using standard clinical monitoring equipment and reported in beats per minute (bpm). | Before sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| Systolic blood pressure measured in mmHg | Systolic blood pressure will be measured using non-invasive monitoring and reported in millimeters of mercury (mmHg). | Before sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| Diastolic blood pressure measured in mmHg | Diastolic blood pressure will be measured using non-invasive monitoring and reported in millimeters of mercury (mmHg). | Before sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| Respiratory rate measured in breaths per minute | Respiratory rate will be measured via standard clinical observation and reported as breaths per minute. | Before sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| Oxygen saturation measured by pulse oximetry (SpO₂ %) | Peripheral oxygen saturation (SpO₂) will be measured using pulse oximetry and reported as percentage (%). | Before sheath removal (baseline), during femoral sheath removal (procedural period), and immediately after sheath removal |
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009422 | Nervous System Diseases |